BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29897900)

  • 1. Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target.
    Chadha S; Vijayan R; Gupta S; Munde M; Gourinath S; Madhubala R
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006575. PubMed ID: 29897900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase.
    Manhas R; Tandon S; Sen SS; Tiwari N; Munde M; Madhubala R
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Validation of
    Chadha S; Mallampudi NA; Mohapatra DK; Madhubala R
    mSphere; 2017; 2(4):. PubMed ID: 28875178
    [No Abstract]   [Full Text] [Related]  

  • 4. Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE.
    Anand S; Madhubala R
    J Biol Chem; 2016 Aug; 291(34):17754-71. PubMed ID: 27382051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase.
    Manhas R; Gowri VS; Madhubala R
    J Biol Chem; 2016 Jan; 291(3):1203-20. PubMed ID: 26586914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity.
    Mittal N; Muthuswami R; Madhubala R
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005590. PubMed ID: 28493888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique hydrophobic cluster near the active site contributes to differences in borrelidin inhibition among threonyl-tRNA synthetases.
    Ruan B; Bovee ML; Sacher M; Stathopoulos C; Poralla K; Francklyn CS; Söll D
    J Biol Chem; 2005 Jan; 280(1):571-7. PubMed ID: 15507440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.
    Kalidas S; Cestari I; Monnerat S; Li Q; Regmi S; Hasle N; Labaied M; Parsons M; Stuart K; Phillips MA
    Eukaryot Cell; 2014 Apr; 13(4):504-16. PubMed ID: 24562907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase.
    Fang P; Yu X; Jeong SJ; Mirando A; Chen K; Chen X; Kim S; Francklyn CS; Guo M
    Nat Commun; 2015 Mar; 6():6402. PubMed ID: 25824639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani.
    Kumar V; Yadav S; Soumya N; Kumar R; Babu NK; Singh S
    Microb Pathog; 2017 Jun; 107():164-174. PubMed ID: 28351708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of borrelidin binding site on threonyl-tRNA synthetase.
    Li M; Zhang J; Liu C; Fang B; Wang X; Xiang W
    Biochem Biophys Res Commun; 2014 Sep; 451(4):485-90. PubMed ID: 25128830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens.
    Kelly P; Hadi-Nezhad F; Liu DY; Lawrence TJ; Linington RG; Ibba M; Ardell DH
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007983. PubMed ID: 32106219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis.
    Varela-M RE; Ochoa R; Muskus CE; Muro A; Mollinedo F
    Parasit Vectors; 2017 Oct; 10(1):458. PubMed ID: 29017516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae.
    Gao YM; Wang XJ; Zhang J; Li M; Liu CX; An J; Jiang L; Xiang WS
    J Agric Food Chem; 2012 Oct; 60(39):9874-81. PubMed ID: 22967236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of borrelidin resistant mutants of Saccharomyces cerivisiae and properties of their threonyl-tRNA-synthetase.
    Nass G; Poralla K
    Mol Gen Genet; 1976 Aug; 147(1):39-43. PubMed ID: 785224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani.
    Verma S; Mehta A; Shaha C
    PLoS One; 2011; 6(9):e25273. PubMed ID: 21966477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Plant like Cytochrome P450 Subfamily CYP710C1 Gene in Leishmania donovani Encodes Sterol C-22 Desaturase and its Over-expression Leads to Resistance to Amphotericin B.
    Bansal R; Sen SS; Muthuswami R; Madhubala R
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007260. PubMed ID: 30943203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of two aminoacyl-tRNA synthetase associated proteins (Endothelial Monocyte Activating Polypeptides 1 and 2) of Leishmania donovani in chemotaxis of human monocytes.
    Tandon S; Muthuswami R; Madhubala R
    Acta Trop; 2021 Dec; 224():106128. PubMed ID: 34509454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the interaction of benzoxaborole inhibitor AN2690 with connective polypeptide 1 (CP1) editing domain of
    Tandon S; Manhas R; Tiwari N; Munde M; Vijayan R; Gourinath S; Muthuswami R; Madhubala R
    J Biosci; 2020; 45():. PubMed ID: 32385222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.
    Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H
    Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.